Brief: Abvc Biopharma Receives $3.175 Million Investment From The Lind Partners To Continue Clinical Trials
Feb 23 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA RECEIVES $3.175 MILLION INVESTMENT FROM THE
LIND
PARTNERS TO CONTINUE CLINICAL TRIALS
Source text for Eikon: ID:nGNX4BJbB
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon